Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule (Q46861751)

25 December 2017

title

Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule (English)

1 reference

25 December 2017

author name string

Yahua Zhang

1

1 reference

25 December 2017

Xiaoyan Zhang

2

1 reference

25 December 2017

Lihong Chen

3

1 reference

25 December 2017

Jing Wu

4

1 reference

25 December 2017

Dongming Su

5

1 reference

25 December 2017

Wendell J Lu

6

1 reference

25 December 2017

Mei-Tsuey Hwang

7

1 reference

25 December 2017

Guangrui Yang

8

1 reference

25 December 2017

Shuo Li

9

1 reference

25 December 2017

Minfen Wei

10

1 reference

25 December 2017

Linda Davis

11

1 reference

25 December 2017

Matthew D Breyer

12

1 reference

25 December 2017

Youfei Guan

13

1 reference

25 December 2017

publication date

20 December 2005

1 reference

25 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

25 December 2017

volume

290

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

F1065-73

1 reference

25 December 2017

Cellular lipid metabolism and the role of lipids in progressive renal disease

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Expression of the liver X receptor alpha and beta in embryonic and adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Cloning and characterization of the human stearoyl-CoA desaturase gene promoter: transcriptional activation by sterol regulatory element binding protein and repression by polyunsaturated fatty acids and cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Nuclear receptors and the control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Influence of molecular packing and phospholipid type on rates of cholesterol exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Role of stearoyl-coenzyme A desaturase in lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Recent insights into stearoyl-CoA desaturase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Regulation of stearoyl-CoA desaturases and role in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

The SREBP pathway--insights from Insigs and insects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Accumulation of foam cells in liver X receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Putative metabolic effects of the liver X receptor (LXR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of L

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00131.2005

10.1152/AJPRENAL.00131.2005

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16368743

1 reference

25 December 2017